International Journal of Cardiology
Volume 142, Issue 1 , Pages 56-64 , 25 June 2010

Low invasive angiogenic therapy for myocardial infarction by retrograde transplantation of mononuclear cells expressing the VEGF gene

  • Kazuhiro Hagikura

      Affiliations

    • Department of Advanced Medicine, Nihon University School of Medicine, Division of Cell Regeneration and Transplantation, 30-1, Oyaguchi, Kami-machi, Itabashi-ku, 173-8610, Tokyo, Japan
    • ,
  • Noboru Fukuda

      Affiliations

    • Department of Advanced Medicine, Nihon University School of Medicine, Division of Cell Regeneration and Transplantation, 30-1, Oyaguchi, Kami-machi, Itabashi-ku, 173-8610, Tokyo, Japan
    • Advanced Research Institute of the Sciences and Humanities, Nihon University, Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Department of Advanced Medicine, Nihon University School of Medicine, Division of Cell Regeneration and Transplantation, Tokyo, Japan, 30-1, Oyaguchi, Kami-machi, Itabashi-ku, Tokyo 173-8610, Japan. Tel./fax: +81 3 3972 8666.
    • ,
  • Shin-ichiro Yokoyama

      Affiliations

    • Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
    • ,
  • Li Yuxin

      Affiliations

    • Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
    • ,
  • Yoshiaki Kusumi

      Affiliations

    • Division of Pathology, Nihon University School of Medicine, Tokyo, Japan
    • ,
  • Taro Matsumoto

      Affiliations

    • Department of Advanced Medicine, Nihon University School of Medicine, Division of Cell Regeneration and Transplantation, 30-1, Oyaguchi, Kami-machi, Itabashi-ku, 173-8610, Tokyo, Japan
    • ,
  • Yukihiro Ikeda

      Affiliations

    • Advanced Research Institute of the Sciences and Humanities, Nihon University, Tokyo, Japan
    • ,
  • Satoshi Kunimoto

      Affiliations

    • Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
    • ,
  • Tadateru Takayama

      Affiliations

    • Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
    • ,
  • Medet Jumabay

      Affiliations

    • Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
    • ,
  • Masako Mitsumata

      Affiliations

    • Division of Pathology, Nihon University School of Medicine, Tokyo, Japan
    • ,
  • Satoshi Saito

      Affiliations

    • Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
    • ,
  • Atsushi Hirayama

      Affiliations

    • Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan
    • ,
  • Hideo Mugishima

      Affiliations

    • Department of Advanced Medicine, Nihon University School of Medicine, Division of Cell Regeneration and Transplantation, 30-1, Oyaguchi, Kami-machi, Itabashi-ku, 173-8610, Tokyo, Japan

Received 30 June 2008 ,Revised 3 December 2008 ,Accepted 12 December 2008.

References 

  1. Herzog EL, Chai L, Krause DS. Plasticity of marrow-derived stem cells. Blood. 2003;102:3483–3493
  2. Asahara T, Murohara T, Sullivan A. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–967
  3. Asahara T, Masuda H, Takahashi T. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221–228
  4. Tateishi-Yuyama E, Matsubara H, Murohara T. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427–435
  5. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Transplanted adult bone marrow cells repair myocardial infarcts in mice. Ann NY Acad Sci. 2001;938:221–229
  6. Orlic D, Kajstura J, Chimenti S. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701–705
  7. Assmus B, Schachinger V, Teupe C. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 2002;106:3009–3017
  8. Schachinger V, Assmus B, Britten MB. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol. 2004;44:1690–1699
  9. Wollert KC, Meyer GP, Lotz J. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141–148
  10. Schachinger V, Erbs S, Elsasser A. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006;27:2775–2783
  11. Symes JF, Losordo DW, Vale PR, et al. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg. 1999;68:830–836
  12. Grines CL, Watkins MW, Helmer G. Angiogenic gene therapy (AGENT) trial in patients with stable angina pectoris. Circulation. 2002;105:1291–1297
  13. Losordo DW, Vale PR, Hendel RC. Phase 1/2 placebo-controlled, double-blind, dose escalating trial of myocardial vascular endothelial growth factor2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation. 2002;105:2012–2018
  14. Vale PR, Losordo DW, Milliken CE. Randomized, single-blind, placebo-controlled pilot study of catheter-based myocardial gene transfer for therapeutic angiogenesis using left ventricular electromechanical mapping in patients with chronic myocardial ischemia. Circulation. 2001;103:2138–2143
  15. Iwaguro H, Yamaguchi J, Kalka C. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation. 2002;105:732–738
  16. Ikeda Y, Fukuda N, Wada M. Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene. Hypertens Res. 2004;27:119–128
  17. Suzuki K, Murtuza B, Smolenski RT. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts. Circulation. 2001;104(suppl):I207–I212
  18. Yau TM, Fung K, Weisel RD, Fujii T, Mickle DA, Li RK. Enhanced myocardial angiogenesis by gene transfer with transplanted cells. Circulation. 2001;104(suppl):I218–I222
  19. Strauer BE, Brehm M, Zeus T, et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation. 2002;106:1913–1918
  20. Tse HF, Kwong YL, Chan JK, Lo G, Ho CL, Lau CP. Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet. 2003;361:47–49
  21. Fuchs S, Satler LF, Kornowski R. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: a feasibility study. J Am Coll Cardiol. 2003;41:1721–1724
  22. Yokoyama S, Fukuda N, Li Y. A strategy of retrograde injection of bone marrow mononuclear cells into the myocardium for the treatment of ischemic heart disease. J Mol Cell Cardiol. 2006;40:24–34
  23. Tomita S, Mickle DA, Weisel RD, et al. Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation. J Thorac Cardiovasc Surg. 2002;123:1132–1140
  24. Kawamoto A, Murayama T, Kusano K. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation. 2004;110:1398–1405
  25. Britten MB, Abolmaali ND, Assmus B. Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation. 2003;108:2212–2218
  26. Chen SL, Fang WW, Ye F, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol. 2004;94:92–95
  27. Henry TD, Annex BH, McKendall GR. The VIVA trial: vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation. 2003;107:1359–1365
  28. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 1998;98:2800–2804
  29. Rosengart TK, Lee LY, Patel SR. Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation. 1999;100:468–474
  30. Vale PR, Losordo DW, Milliken CE, et al. Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation. 2000;102:965–974
  31. Kamihata H, Matsubara H, Nishiue T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001;104:1046–1052
  32. Rutanen J, Rissanen TT, Markkanen JE. Adenoviral catheter-mediated intramyocardial gene transfer using the mature form of vascular endothelial growth factor-D induces transmural angiogenesis in porcine heart. Circulation. 2004;109:1029–1035
  33. von Degenfeld G, Raake P, Kupatt C. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J Am Coll Cardiol. 2003;42:1120–1128
  34. Thompson CA, Nasseri BA, Makower J, et al. A novel nonsurgical approach for myocardial cell transplantation. J Am Coll Cardiol. 2003;41:1964–1971
  35. Orlic D. Stem cell repair in ischemic heart disease: an experimental model. Int J Hematol. 2002;76:144–145
  36. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature. 2002;416:542–545
  37. Ye L, Haider HKh, Tan R, et al. Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-165 for cardiac repair. Circulation. 2007;116:I113–I120
  38. Young PP, Hofling AA, Sands MS. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc Natl Acad Sci USA. 2002;99:11951–11956
  39. Vandervelde S, van Luyn MJ, Tio RA, Harmsen MC. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol. 2005;39:363–376
  40. Tatsumi T, Ashihara E, Yasui T. Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarction. Circ J. 2007;71:1199–1207
  41. Luo Z, Diaco M, Murohara T, Ferrara N, Isner JM, Symes JF. Vascular endothelial growth factor attenuates myocardial ischemia–reperfusion injury. Ann Thorac Surg. 1997;64:993–998
  42. Tateno K, Minamino T, Toko H. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res. 2006;98:1194–1202
  43. Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131:149–150

☆ This work was supported in part by a grant from New Energy and Industrial Technology Development Organization (NEDO) and by a grant Culture to Nihon University and from the Ministry of Education, Science, Sports, and Culture of Japan (17390237).

PII: S0167-5273(08)01491-5

doi: 10.1016/j.ijcard.2008.12.108

International Journal of Cardiology
Volume 142, Issue 1 , Pages 56-64 , 25 June 2010

Article Tools

* Image Usage & Resolution